BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 37955537)

  • 21. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway.
    Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z
    Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor suppressive effect of scavenger receptor class A member 5 overexpression in colorectal cancer by regulating PI3K/AKT/mTOR pathway.
    Li Y; Peng F; Tan X; Wang J; Xu Y
    Genes Genomics; 2021 Oct; 43(10):1189-1198. PubMed ID: 34417976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway.
    Yin F; Huang X; Xuan Y
    Dis Markers; 2021; 2021():9950663. PubMed ID: 34512817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 20(S)-Protopanaxadiol-Induced Apoptosis in MCF-7 Breast Cancer Cell Line through the Inhibition of PI3K/AKT/mTOR Signaling Pathway.
    Zhang H; Xu HL; Wang YC; Lu ZY; Yu XF; Sui DY
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29614812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-508-5p serves as an anti-oncogene by targeting S100A16 to regulate AKT signaling and epithelial-mesenchymal transition process in lung adenocarcinoma cells.
    Wu C; Yang J; Lin X; Li R; Wu J
    Am J Med Sci; 2023 Jun; 365(6):520-531. PubMed ID: 36967030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mangiferin inhibits cell migration and angiogenesis via PI3K/AKT/mTOR signaling in high glucose‑ and hypoxia‑induced RRCECs.
    Shi J; Lv H; Tang C; Li Y; Huang J; Zhang H
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33899114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-treatment with BEZ235 enhances chemosensitivity of A549/DDP cells to cisplatin via inhibition of PI3K/Akt/mTOR signaling and downregulation of ERCC1 expression.
    Xia A; Li H; Li R; Lu L; Wu X
    Oncol Rep; 2018 Oct; 40(4):2353-2362. PubMed ID: 30066933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pseudouridylate Synthase 7 Promotes Cell Proliferation and Invasion in Colon Cancer Through Activating PI3K/AKT/mTOR Signaling Pathway.
    Du J; Gong A; Zhao X; Wang G
    Dig Dis Sci; 2022 Apr; 67(4):1260-1270. PubMed ID: 33811565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.
    Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH
    Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of T-cadherin inhibits the proliferation of oral squamous cell carcinoma through the PI3K/AKT/mTOR intracellular signalling pathway.
    Wang Q; Zhang X; Song X; Zhang L
    Arch Oral Biol; 2018 Dec; 96():74-79. PubMed ID: 30195142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PDGF-BB/PDGFRβ promotes epithelial-mesenchymal transition by affecting PI3K/AKT/mTOR-driven aerobic glycolysis in Wilms' tumor G401 cells.
    Guo JQ; Wang CD; Tang HY; Sang BT; Liu X; Yi FP; Wu XM
    Cell Biol Int; 2022 Jun; 46(6):907-921. PubMed ID: 35165984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The circEPSTI1/mir-942-5p/LTBP2 axis regulates the progression of OSCC in the background of OSF via EMT and the PI3K/Akt/mTOR pathway.
    Wang J; Jiang C; Li N; Wang F; Xu Y; Shen Z; Yang L; Li Z; He C
    Cell Death Dis; 2020 Aug; 11(8):682. PubMed ID: 32826876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LncRNA ENST00113 promotes proliferation, survival, and migration by activating PI3K/Akt/mTOR signaling pathway in atherosclerosis.
    Yao X; Yan C; Zhang L; Li Y; Wan Q
    Medicine (Baltimore); 2018 Apr; 97(16):e0473. PubMed ID: 29668625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repressing IRS1/2 by NT157 inhibits the malignant behaviors of ovarian cancer through inactivating PI3K/AKT/mTOR pathway and inducing autophagy.
    Li CX; Men CD; Yang WH; Chen R; Zhu JH; Cheng ZP
    Kaohsiung J Med Sci; 2023 Apr; 39(4):377-389. PubMed ID: 36727938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway.
    Zeng L; Liao Q; Zou Z; Wen Y; Wang J; Liu C; He Q; Weng N; Zeng J; Tang H; Fang R; Lei Z; Tang Z; Yang X; Cui S
    Cell Physiol Biochem; 2018; 51(3):1221-1236. PubMed ID: 30481766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LHX6 inhibits the proliferation, invasion and migration of breast cancer cells by modulating the PI3K/Akt/mTOR signaling pathway.
    Bi QJ; Men XJ; Han R; Li GL
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3067-3073. PubMed ID: 29863252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. P53 suppresses cell proliferation, metastasis, and angiogenesis of osteosarcoma through inhibition of the PI3K/AKT/mTOR pathway.
    Song R; Tian K; Wang W; Wang L
    Int J Surg; 2015 Aug; 20():80-7. PubMed ID: 25936826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. S100 Calcium Binding Protein A16 Promotes Cell Proliferation by triggering LATS1 ubiquitin degradation mediated by CUL4A ligase to inhibit Hippo pathway in Glioma development.
    Hu Y; Zhang R; Lu S; Zhang W; Wang D; Ge Y; Jiang F; Qin X; Liu Y
    Int J Biol Sci; 2023; 19(7):2034-2052. PubMed ID: 37151881
    [No Abstract]   [Full Text] [Related]  

  • 39. [P4HA2 promotes occurrence and progression of liver cancer by regulating the PI3K/Akt/mTOR signaling pathway].
    Shang L; Jiang W; Zhang J; Wu W
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 May; 42(5):665-672. PubMed ID: 35673909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Desumoylating Isopeptidase 2 (DESI2) Inhibits Proliferation and Promotes Apoptosis of Pancreatic Cancer Cells through Regulating PI3K/AKT/mTOR Signaling Pathway.
    Ou X; Zhang GT; Xu Z; Chen JS; Xie Y; Liu JK; Liu XP
    Pathol Oncol Res; 2019 Apr; 25(2):635-646. PubMed ID: 30411297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.